相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
常温,避光
- 克隆性:
单克隆
- 抗体名:
CD86 / B7-2 / B70 / CD28LG2 抗体
抗体类型: Rabbit Polyclonal Antibody ( Antibody Purification Platform )
抗体宿主 : Rabbit IgG
缓冲液 : 0.2 μm filtered solution in PBS, 5% trehalose may be added in some batches. Please read the hardcopy of COA or contact our customer service to confirm the formulation.
制备方法 : Produced in rabbits immunized with purified, human cell-derived, recombinant human CD86 / B7-2 ( rh CD86 ; Catalog#10699-H08H ; NP_008820.2 ; Met 1- His 239 ). CD86 specific IgG was purified by human CD86 affinity chromatography
CD86 / B7-2 / B70 / CD28LG2抗体背景综述
The B-lymphocyte activation antigen B7-2 (referred to as B70), also known as CD86, is a member of the cell surface immunoglobulin superfamily and is constitutively expressed on interdigitating dendritic cells, Langerhans cells, peripheral blood dendritic cells, memory B cells, and germinal center B cells. B7-2 exists predominantly as a monomer on cell surfaces and interacts with two co-stimulatory receptors CD28 and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) expressed on T cells, and thus induces the signal pathways which regulate T cell activation and tolerance, cytokine production, and the generation of CTL. Binding of B7-2 with CD28 induces the activation of T cell, whereas CTLA-4 acts as a negative regulator and diminishes the immune responses. Recent study has revealed that B7-2 promotes the generation of a mature APC repertoire and promotes APC function and survival. It is indicated that contacts between B and T helper cells mediated by CD86 encourage signals for the proliferation and IgG secretion of normal B cells and B cell lymphomas. Furthermore, the B7 proteins are also involved in innate immune responses by activating NF-κB-signaling pathway in macrophages. CD86 is regarded as a promising candidate for immune therapy.
CD86 / B7-2 / B70 / CD28LG2 抗体相关产品如下:xy-7103R THAP1核凋亡因子THAP1抗体
xy-7105R TIA1细胞毒颗粒相关蛋白TIA-1抗体
xy-7104R THYN1胸腺细胞核蛋白1抗体
xy-7551R TNFAIP3 interacting protein 3肿瘤坏死因子α诱导相互作用蛋白3抗体
xy-12097R TRPV3辣椒素受体3抗体
xy-12105R TEX261TEX261蛋白抗体
xy-2087R TSHR促甲状腺素受体抗体
xy-3457R Phospho-TrkA(Tyr674 + Tyr675) + TrkB(Tyr706 + Tyr707)磷酸化酪氨酸激酶A抗体
xy-1444R TLR3Toll样受体3抗体
xy-1450R TCRGT细胞受体γ抗体
xy-4514R Transketolase (CT)转酮醇酶(转羟乙醛酶)抗体(C端)
xy-1215R TPH色氨酸羟化酶抗体
xy-1214R TRAIL肿瘤坏死因子相关凋亡诱导配体抗体
xy-0152R Prealbumin转甲状腺素蛋白/前白蛋白抗体
xy-1151R TRF1端粒体复制结合因子1抗体
xy-0193R TrkA酪氨酸激酶A抗体
xy-1212R TRAF1肿瘤坏死因子受体相关因子1抗体
xy-1213R TRAF2 肿瘤坏死因子受体相关因子2抗体
xy-0157R Tau protein微管相关蛋白抗体
xy-0822R TARDBPTar DNA 结合蛋白43抗体
xy-1039R Tenascin C细胞粘合素(固生蛋白)抗体
xy-0535R TFF3三叶肽因子3抗体
xy-1144R TFPI-2组织因子途径抑制剂-2抗体
xy-0066R TGF alpha转移生长因子α抗体(TGFα)
xy-0103R TGF Beta 1转化生长因子β1抗体(TGFβ1)
xy-0100R TGF beta 2 Propeptide转移生长因子β2抗体(TGFβ2)
xy-0099R TGF beta 3 propeptide转移生长因子β3抗体(TGFβ3)
xy-0117R TGF beta Receptor II转移生长因子β受体2抗体(TGF-βRⅡ,TGFβRⅡ)
xy-0638R TGF beta Receptor I转移生长因子β受体1抗体
xy-0447R Thyroid peroxidase甲状腺过氧化物酶抗体
xy-1202R TRADD肿瘤坏死因子受体1相关死亡域蛋白抗体
xy-1217R TSARG3生精细胞凋亡相关基因3抗体
xy-0339R T3三碘甲狀腺素T3抗体
xy-0632R Thioster-containing protein 1按蚊硫酯包含蛋白-1抗体
xy-1909R Telomerase Binding Protein, P23端粒酶结合蛋白P23抗体
xy-1923R TSARG6生精细胞凋亡相关基因6抗体
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验人转录因子E2F1 ( E2F1 )ELISA 试剂盒 原理 本实验采用双抗体夹心 ABC-ELISA 法。用抗人 E2F1 单抗包被于酶标板上,标准品和样品中的 E2F1与单抗结合,加入生物素化的抗人 E2F1 ,形成免疫复合物连接在板上,辣根过氧化物酶标记的 Streptavidin 与生物素结合,加入底物工作液显蓝色,最后加终止液硫酸,在 450nm 处测 OD 值,E2F1 浓度与 OD 值成正比
X性联无丙种球蛋白血症(X-linked agammagl,bulinemia,XLA)是临床上首次确定的体液免疫缺陷病,由Brutor于1952年报道,故又称Bruton病。XLA作为常见的原发性免疫缺陷病之一,特点为血清中各类免疫球蛋白缺乏,或只能测得微量的抗体。外周血和淋巴组织中B细胞减少或完全缺乏,淋巴结中无生发中心和浆细胞。本病起病早,在出生数月后当患儿体内的母源性抗体水平下降时开始发病。临床表现为反复化脓性感染,患者细胞免疫功能不受影响(部分患者有T细胞数量减少),主要缺陷
ChIP是一种强大的确定蛋白或者组蛋白修饰在基因组上定位的实验方法。染色质被分离出来后采用抗体与抗原的结合来判定目的蛋白是否结合在特定的DNA序列上或者判定目的蛋白结合位点在全基因组范围的分布(微阵列或DNA序列)。这种方法具有空间性与时效性。该实验设计为如何在细胞中进行ChIP实验提供了详细的步骤。1. 交联和细胞收获甲醛可以将蛋白质交联到DNA上。交联结果的好坏决定于交联时间的把握。我们建议样品交联的时间一般为2-30分钟。过度的交联会减少抗原的结合性和超声断裂的效率。抗原决定簇也会被掩盖
技术资料暂无技术资料 索取技术资料





